Docusate Sodium And Sennosides Tablet
Product Images NDC 87717-502

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Docusate Sodium And Sennosides (NDC 87717-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Morepen Bio Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage & Administration (Dosage And Administration)

A dosing directions table for Docusate Sodium and Sennosides tablets detailing recommended starting and maximum dosages by age group. Instructions specify dosing preferences such as taking the medication at bedtime or as directed by a doctor. Age groups range from adults and children 12 years and older to children under 2 years, with dosage amounts varying accordingly.*

FDA Label Image

Indications & Usage (Indications And Usage)

This image shows a Drug Facts panel section titled 'Uses' for Docusate Sodium and Sennosides tablets. It states that the product relieves occasional constipation (irregularity) and generally produces a bowel movement in 6 to 12 hours.*

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

This drug facts panel excerpt contains a safety warning advising to keep the product out of reach of children and instructions to seek medical help or contact a Poison Control Center immediately in case of overdose.*

FDA Label Image

Purpose (Purpose)

Drug Facts panel showing active ingredients and their purpose for Docusate Sodium and Sennosides tablets. It lists Docusate sodium USP 50 mg as a stool softener and Sennosides 8.6 mg as a laxative.*

FDA Label Image

Primary Display Panel 1000 Tablets (Sennosides And Docusate Tab Pdp)

Drug Facts panel for Docusate Sodium 50 mg and Sennosides 8.6 mg Tablets by Morepen Bio Inc. It lists active ingredients, their purpose as stool softener and laxative, uses, warnings, directions for dosage by age group, inactive ingredients, storage instructions, and contact information for questions or comments. The package contains 1000 tablets.*

FDA Label Image

Storage And Handling (Storage And Handling)

A text panel labeled 'Other information' detailing the contents per tablet, including calcium 17.7 mg and sodium 4.4 mg, noted as very low sodium. It also provides storage instructions, recommending storage at 25°C (77°F) with permitted excursions between 15-30°C (59-86°F).*

FDA Label Image

Active Ingredient (Active Ingredient)

Drug Facts panel listing active ingredients per tablet of Docusate Sodium 50 mg and Sennosides 8.6 mg, with their purposes as stool softener and laxative, respectively.*

FDA Label Image

Inactive Ingredients (Inactive Ingredients)

A drug facts panel listing inactive ingredients for Docusate Sodium and Sennosides tablets. Ingredients include colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate, FD&C Yellow #5 Lake, FD&C Yellow #6 Lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide. The panel notes FD&C Yellow #5 Lake (tartrazine) as a color additive.*

FDA Label Image

Questions & Comments (Question Or Comments)

Contact information panel for questions or comments regarding the product Docusate Sodium and Sennosides. It provides a toll-free phone number available Monday to Friday, 9 AM to 5 PM EST, an email address at morepen.com, and FDA contact details including a phone number and website for MedWatch reporting.*

FDA Label Image

Warnings (Warnings)

Warning and precaution text panel for Docusate Sodium and Sennosides tablets. It includes warnings about not using with mineral oil or for extended periods, advisories to consult a doctor if certain symptoms occur, instructions to stop use with rectal bleeding or lack of bowel movement, and guidance for pregnant or breastfeeding users along with keeping the product out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.